The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins

Annual Review of Immunology - Tập 25 Số 1 - Trang 21-50 - 2007
James N. Arnold1, Mark R. Wormald1, Robert B. Sim1, Pauline M. Rudd1, Raymond A. Dwek1
1Oxford Glycobiology Institute, Department of Biochemistry and 2MRC Immunochemistry Unit, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom;, , , ,

Tóm tắt

Immunoglobulins are the major secretory products of the adaptive immune system. Each is characterized by a distinctive set of glycoforms that reflects the wide variation in the number, type, and location of their oligosaccharides. In a given physiological state, glycoform populations are reproducible; therefore, disease-associated alterations provide diagnostic biomarkers (e.g., for rheumatoid arthritis) and contribute to disease pathogenesis. The oligosaccharides provide important recognition epitopes that engage with lectins, endowing the immunoglobulins with an expanded functional repertoire. The sugars play specific structural roles, maintaining and modulating effector functions that are physiologically relevant and can be manipulated to optimize the properties of therapeutic antibodies. New molecular models of all the immunoglobulins are included to provide a basis for informed and critical discussion. The models were constructed by combining glycan sequencing data with oligosaccharide linkage and dynamics information from the Glycobiology Institute experimental database and protein structural data from “The Protein Data Bank.”

Từ khóa


Tài liệu tham khảo

10.1098/rstb.1975.0070

10.1038/266031a0

Dwek RA, 1995, Soc. Trans, 23, 1

10.1021/bi00512a001

10.1038/316452a0

10.1038/nm0395-237

10.1146/annurev.bi.57.070188.004033

10.1038/40677

10.1126/science.291.5512.2370

10.1016/0968-0004(94)90205-4

10.1128/JVI.76.14.7306-7321.2002

10.1126/science.1083182

10.1146/annurev.immunol.17.1.109

10.1146/annurev.bi.48.070179.004525

10.1016/S0161-5890(00)00105-X

10.1074/jbc.M203258200

10.1074/jbc.M107478200

Dong X, 1999, J. Immunol, 163, 5427, 10.4049/jimmunol.163.10.5427

10.1042/bst0110130

10.1016/S0022-2836(02)00244-9

10.1093/glycob/cwg079

10.1042/bj2680529

10.1021/bi9621472

10.1084/jem.167.5.1731

Dwek RA, 1983, Period. Biol., 85, 21

Padlan EA, 1991, Proc. Natl. Acad. Sci. USA, 80, 6632

10.1016/S0022-2836(02)01250-0

Lund J, 1996, J. Immunol, 157, 4963, 10.4049/jimmunol.157.11.4963

10.1111/j.1600-065X.1978.tb01458.x

Baenziger J, 1974, J. Biol. Chem., 249, 1897, 10.1016/S0021-9258(19)42870-6

Baenziger J, 1974, J. Biol. Chem., 249, 1889, 10.1016/S0021-9258(19)42869-X

10.4049/jimmunol.173.11.6831

10.1016/0167-5699(93)90263-K

10.1111/j.1365-2567.2004.01958.x

10.1042/bj2710285

10.4049/jimmunol.167.5.2861

Delacroix DL, 1982, Immunology, 47, 383

10.1042/bj2990261

10.1074/jbc.273.4.2260

Baenziger J, 1974, J. Biol. Chem., 249, 7260, 10.1016/S0021-9258(19)42100-5

10.1016/0161-5890(94)90157-0

10.1046/j.1365-3083.1999.00628.x

10.1152/physrev.1995.75.3.591

10.4049/jimmunol.167.9.5185

10.1074/jbc.M301436200

Wiersma EJ, 1998, J. Immunol, 160, 5979, 10.4049/jimmunol.160.12.5979

Norderhaug IN, 1999, Crit. Rev. Immunol, 19, 481

10.1146/annurev.micro.51.1.311

10.4049/jimmunol.172.11.6838

Schroten H, 1998, Infect. Immun, 66, 3971, 10.1128/IAI.66.8.3971-3973.1998

Wold AE, 1990, Infect. Immun., 58, 3073, 10.1128/iai.58.9.3073-3077.1990

10.1042/bst025323s

10.1073/pnas.90.5.2035

10.1126/science.8018146

10.1016/S1074-7613(02)00341-2

Van Boxel JA, 1972, J. Immunol., 109, 648, 10.4049/jimmunol.109.3.648

10.1016/j.jmb.2005.07.072

10.1073/pnas.79.9.2850

Mellis SJ, 1983, J. Biol. Chem, 258, 11546, 10.1016/S0021-9258(17)44262-1

10.1021/bi972465g

10.1016/S0092-8674(00)81855-3

10.1126/science.286.5446.1882

10.1016/S0959-440X(98)80148-6

10.1016/j.febslet.2004.04.045

10.1111/j.1432-1033.1991.tb15995.x

Baker MD, 1986, J. Immunol, 137, 1724, 10.4049/jimmunol.137.5.1724

10.1074/jbc.M504528200

Chapman A, 1979, J. Biol. Chem., 254, 824, 10.1016/S0021-9258(17)37879-1

Chapman A, 1979, J. Biol. Chem., 254, 816, 10.1016/S0021-9258(17)37878-X

10.1093/glycob/5.2.175

10.1111/j.1744-313X.1979.tb00692.x

Mellis SJ, 1983, J. Biol. Chem, 258, 11557, 10.1016/S0021-9258(17)44263-3

Baenziger J, 1974, J. Biol. Chem., 249, 7270, 10.1016/S0021-9258(19)42101-7

10.1016/j.carres.2004.07.011

10.1111/j.1699-0463.1996.tb00724.x

Reinholdt J, 1990, Infect. Immun, 58, 1186, 10.1128/iai.58.5.1186-1194.1990

10.1006/jmbi.1998.2556

10.1182/blood.V99.7.2562

Chandrasekaran EV, 1981, J. Biol. Chem, 256, 1549, 10.1016/S0021-9258(19)69839-X

10.1084/jem.168.3.1099

10.1002/j.1460-2075.1991.tb07819.x

10.1021/bi00341a040

10.1042/bj3140621

10.4049/jimmunol.172.9.5489

Radcliffe CM, Arnold JN, Suter DM, Wormald MR, Harvey DJ, et al. 2007. Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B cell receptor.J. Biol. Chem.In press

10.1002/j.1460-2075.1987.tb02359.x

10.3109/10409239709085144

10.1074/jbc.M009483200

10.1016/S0165-2478(02)00019-6

10.1016/j.jmb.2004.01.007

10.1074/jbc.M510171200

Rudd PM, 1994, Immunology, 83, 99

10.1073/pnas.88.20.9238

10.1016/S0161-5890(01)00006-2

Spiegelberg HL, 1983, Fed. Proc, 42, 124

Capron M, 1981, J. Immunol, 126, 2087, 10.4049/jimmunol.126.6.2087

10.1172/JCI108679

Yodoi J, 1979, J. Immunol., 122, 2577, 10.4049/jimmunol.122.6.2577

10.1038/366421a0

10.1073/pnas.86.18.7118

10.1038/338649a0

Richards ML, 1990, J. Immunol, 144, 2638, 10.4049/jimmunol.144.7.2638

10.1016/S0161-5890(99)00036-X

10.1111/j.1365-2249.1990.tb05179.x

10.1097/01.ASN.0000115401.07980.0C

10.1084/jem.194.4.417

10.1016/0896-8411(91)90173-A

10.1073/pnas.91.13.6123

10.1016/0896-8411(89)90148-0

10.1006/jaut.1996.0104

10.1002/art.22171

10.1016/S0140-6736(87)92621-3

10.1172/JCI115643

Garred P, 2000, J. Rheumatol., 27, 26

10.1172/JCI109998

10.1046/j.1523-1755.2001.060003969.x

10.1159/000422410

10.1046/j.1523-1755.2001.0590031077.x

10.1159/000423879

Hiki Y, 1996, J. Am. Soc. Nephrol., 7, 955, 10.1681/ASN.V76955

Floege J, 2000, J. Am. Soc. Nephrol, 11, 2395, 10.1681/ASN.V11122395

10.1046/j.1365-3083.2000.00685.x

10.1046/j.1365-2141.2003.04064.x

10.1073/pnas.91.14.6423

10.1021/bi00183a022

10.4269/ajtmh.1994.50.585

10.1128/IAI.72.12.7115-7123.2004

Trkola A, 1996, J. Virol., 70, 1100, 10.1128/jvi.70.2.1100-1108.1996

10.1038/6179

10.1093/glycob/5.8.813

10.1126/science.1088166

10.1002/eji.1830230216

10.1097/00007890-199912150-00005

10.1016/S1389-0344(01)00102-2

10.1016/S0958-1669(02)00351-8

10.1073/pnas.0832472100

10.1016/j.pbi.2005.01.003

10.1093/nar/28.1.235

10.1126/science.2333521

10.1038/ni811

10.1038/35018500

10.1006/abio.1996.0351

10.1080/10409239891204198